跳至主要内容
临床试验/NCT06769204
NCT06769204尚未招募3 期

Safety and Efficacy of Lidocaine Prilocaine Spray in Reducing Pain During Hysterosalpingography in Women With Primary Infertility

Cairo University0 个研究点目标入组 90 人开始时间: 2025年2月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
尚未招募
入组人数
90
主要终点
pain during Cervical instrumentation of the tenaculum and cannula

研究概览

简要总结

We aim to assess the Safety and Efficacy of Cervical Lidocaine Prilocaine Spray in Reducing Pain During Hysterosalpingography in women with primary infertility

详细描述

We aim to assess the Safety and Efficacy of Cervical Lidocaine Prilocaine Spray in Reducing Pain During Hysterosalpingography in Women with Primary Infertility.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women aged 18-45 years. Diagnosed with primary infertility (no prior pregnancy after at least 12 months of unprotected intercourse) and scheduled for HSG as part of infertility evaluation.

排除标准

  • Known allergy or hypersensitivity to lidocaine, prilocaine, or any components of the spray.
  • Current pregnancy or suspicion of pregnancy.
  • Active pelvic inflammatory disease or history of severe pelvic infections within the last 6 months.
  • Use of systemic analgesics, sedatives, or anesthetics within 24 hours prior to the procedure.

研究组 & 干预措施

lidocaine prilocaine

Experimental

干预措施: EMLA SPRAY (Drug)

placebo

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

pain during Cervical instrumentation of the tenaculum and cannula

时间窗: 1 minute

pain is measured using 10 cm VISUAL Analog scale where 0 denotes no pain and 10 maximum pain felt

次要结局

  • pain At the end of uterine filling(5 minutes)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Samy aly ashour

professor

Cairo University

相似试验